Home/Library/Insilico Medicine Rentosertib: First AI-Designed Drug in Phase IIa (Nature Medicine)Case StudiesInsilico Medicine Rentosertib: First AI-Designed Drug in Phase IIa (Nature Medicine)DetailsPublisherInsilico Medicine / Nature MedicineDomainBusiness & ProductCategoryCase StudiesType GroupResearch & PapersTypeResearch PaperBest ForOperationsSkill LevelExpertAccessFreeTopicAI drug discovery through Phase IIa clinical validationRelated in Case StudiesCAA Tech Corner #1: Artificial IntelligenceChasealumHow JP Morgan’s COIN AI Platform Revolutionizes Contract Analysis and Legal OperationsGobeyondHow JPMorgan Uses AI to Save 360,000 Legal Hours a Year | by Ahmed Raza | MediumMediumCase Studies: How JPMorgan Chase Cracked the AI Code While Others Waited - 5D Vision5Dvision13 Ways JP Morgan Is Using AI [In Depth Case Study][2026] - DigitalDefynd EducationDigitaldefyndAI Case Study: AI for Automated Document Processing at JPMorgan (COIN)RedresscomplianceOpen ResourceSave to pathBack to library
